Molecular mechanism of activating protein-4 regulated growth of hepatocellular carcinoma

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12441-12447

  Ge, Zhong ^a   Zhang, Bao ^c   Bu, Xiangyang ^b   Wang, Youlong ^c   Xiang, Lei ^c   Tan, Jingwang ^c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c General Hospital of the Chinese People's Liberation Army and Military Medical Postgraduate College   (China)

Author keywords

Activating protein 4; c myc; Hepatocellular carcinoma; p21; Wnt signaling

Indexed keywords

BETA CATENIN; MYC PROTEIN; PHOSPHOPROTEIN; PHOSPHORYLATED BETA CATENIN; PROTEIN P21; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 4; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; REPIN1 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CANCER SURGERY; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WNT SIGNALING PATHWAY; BIOLOGICAL MODEL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS P21(RAS); WNT SIGNALING PATHWAY;

EID: 84925283442     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2562-0     Document Type: Article

References (19)

1. Wang L, Yao M, Dong Z, Zhang Y, Yao D. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biol. 2014;35:9–20.
2. Wang H, Chen L. Tumor microenviroment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol. 2013;28 Suppl 1:43–8.
3. Han MS, Moon KS, Lee KH, Cho SB, Lim SH, Jang WY, et al. Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor. BMC Cancer. 2013;13:567.
4. Wang J, Su H, Han X, Xu K. Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma. Tumour Biol. 2014. doi:10.1007/s13277-014-2384-0.
5. Jung P, Hermeking H. The c-MYC-ap4-p21 cascade. Cell Cycle. 2009;8:982–9.
6. Jung P, Menssen A, Mayr D, Hermeking H. Ap4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A. 2008;105:15046–51.
7. Goc A, Al-Azayzih A, Abdalla M, Al-Husein B, Kavuri S, Lee J, et al. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion. J Biol Chem. 2013;288:3025–35.
8. Chiang YA, Shao W, Xu XX, Chernoff J, Jin T. P21-activated protein kinase 1 (Pak1) mediates the cross talk between insulin and β-catenin on proglucagon gene expression and its ablation affects glucose homeostasis in male C57BL/6 mice. Endocrinology. 2013;154:77–88.
9. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.
10. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol. 2005;25:3752–62.
11. Jackstadt R, Roh S, Neumann J, Jung P, Hoffmann R, Horst D, et al. Ap4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med. 2013;210:1331–50.
12. Hayward WS, Neel BG, Astrin SM. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature. 1981;290:475–80.
13. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103:18261–6.
14. Kaur P, Mani S, Cros MP, Scoazec JY, Chemin I, Hainaut P, et al. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumour Biol. 2012;33:325–36.
15. Huang L, Li MX, Wang L, Li BK, Chen GH, He LR, et al. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation. Tumour Biol. 2011;32:233–40.
16. Wands JR, Kim M. Wnt/beta-catenin signaling and hepatocellular carcinoma. Hepatology. 2014;60:452–4.
17. White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology. 2012;142:219–32.
18. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, et al. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res. 2009;69:3764–71.
19. Hu BS, Zhao G, Yu HF, Chen K, Dong JH, Tan JW. High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. Tumour Biol. 2013;34:271–6.